eltrombopag
- Product NDC
- 72205-157
- 11-digit product format
- 722050157
- Labeler code
- 72205
- Product ID
- 72205-157_5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eltrombopag olamine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Novadoz Pharmaceuticals LLC
- Application
- ANDA220250
- Marketing category
- ANDA
- Marketing start
- 2026-01-14
- Substance
- ELTROMBOPAG OLAMINE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- eltrombopag
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ELTROMBOPAG OLAMINE | 25 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 4U07F515LG |
| Rxcui | 825421, 825427, 884617, 1245001 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 349df11e-99eb-4fff-8cd5-538adda21b14 | Product name | 3 | 20251110 |
| 4db6dd95-5e83-4752-b5e1-62f824423c50 | Product name | 1 | 20241217 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
| fa996cde-a51d-4f68-1429-4f06c00a39f8 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72205-157-30 | eltrombopag | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72205-157-30 | EA - Each | 72205-157 | e20849c3-476e-4e3b-94ea-7fdde377b130 | 1 | 2026-02-05 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1245001 | eltrombopag 12.5 MG Oral Tablet | PSN | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825421 | eltrombopag 25 MG Oral Tablet | PSN | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825427 | eltrombopag 50 MG Oral Tablet | PSN | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 884617 | eltrombopag 75 MG Oral Tablet | PSN | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 1245001 | eltrombopag 12.5 MG Oral Tablet | SCD | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825421 | eltrombopag 25 MG Oral Tablet | SCD | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825427 | eltrombopag 50 MG Oral Tablet | SCD | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 884617 | eltrombopag 75 MG Oral Tablet | SCD | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 1245001 | eltrombopag (as eltrombopag olamine) 12.5 MG Oral Tablet | SY | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825421 | eltrombopag (as eltrombopag olamine) 25 MG Oral Tablet | SY | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 825427 | eltrombopag (as eltrombopag olamine) 50 MG Oral Tablet | SY | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
| 884617 | eltrombopag (as eltrombopag olamine) 75 MG Oral Tablet | SY | 5a9ec8c8-3c0b-4f11-848c-c04ccee0d44f | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72205-157-30 | 72205015730 | 30 TABLET, FILM COATED in 1 BOTTLE (72205-157-30) | 2026-01-14 | No | No | Current |